KJ Meds Private Limited
About KJ Meds Private Limited
Data last updated:
KJ Meds Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 10 October 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2022PTC391815.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jaya Bhat Mugulthimoole and Rasika Ganapathi Bhat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 104 Dheeraj Valley Bldg 2 Near Sai Baba Complex, Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.35 Lakh. For the same year it recorded a net profit of ₹54,185 (net margin 40.2%) and EBITDA of ₹54,185 (EBITDA margin 40.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
KJ Meds Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressA – 104 Dheeraj Valley Bldg 2 Near Sai Baba Complex, Mumbai, Maharashtra, India – 400063
- IndustryChemicals, Other Chemical Product, Manufacturing, Fine Chemicals And Other Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of KJ Meds is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of KJ Meds Private Limited, buy the company report.
Financials of KJ Meds Private Limited
FY 2025 filings availableKJ Meds Private Limited reported revenue of ₹1.35 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹54,185 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹54,185 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 40.2% | |
| Net Profit Margin | 40.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of KJ Meds Private Limited, buy the company report.
Board of directors of KJ Meds Private Limited
KJ Meds has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaya Bhat Mugulthimoole | Director | 10 Oct 2022 | 4 Years 0 Months | Current |
| Rasika Ganapathi Bhat | Director | 10 Oct 2022 | 4 Years 0 Months | Current |
Peer comparison
KJ Meds Private Limited is compared with the 8 companies closest to it by revenue in the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aelius Consulting Private Limited | ₹1.35 Lakh (FY 2016) | -81.0% | Thane, Maharashtra, India | |||
| TSM Internet Private Limited | ₹1.35 Lakh (FY 2019) | Kannauj, Uttar Pradesh, India | ||||
| Areca Multitrade Private Limited | ₹1.35 Lakh (FY 2023) | -97.0% | Ranchi, Jharkhand, India | |||
| Avinash Tradecom Private Limited | ₹1.35 Lakh (FY 2025) | -95.0% | Anuppur, Madhya Pradesh, India | |||
| Pratham Carbon-Free Vision Private Limited | ₹1.35 Lakh (FY 2024) | -87.0% | Ulhasnagar, Maharashtra, India | |||
| KJ Meds Private Limitedthis company | ₹1.35 Lakh (FY 2024) | ₹54,185 | 40.2% | Mumbai, Maharashtra, India | ||
| Arya Empire Private Limited | ₹1.35 Lakh (FY 2019) | Pune, Maharashtra, India | ||||
| Irevize Services Private Limited | ₹1.34 Lakh (FY 2025) | -7.0% | Delhi, India | |||
| Datosmind Private Limited | ₹1.34 Lakh (FY 2022) | -94.0% | Bangalore, Karnataka, India |
To see the full peer comparison of KJ Meds Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving KJ Meds Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for KJ Meds Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for KJ Meds Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
KJ Meds Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Jaya Bhat Mugulthimoole was appointed as Director on 10 Oct 2022.
Frequently asked questions
KJ Meds is an active private limited company based in Mumbai, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 10 October 2022 (4+ years old) and is registered under CIN U24299MH2022PTC391815.
KJ Meds has 2 current directors:
- Jaya Bhat Mugulthimoole - Director
- Rasika Ganapathi Bhat - Director
The latest financial statements of KJ Meds on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of KJ Meds is U24299MH2022PTC391815. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
KJ Meds was incorporated on 10 October 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of KJ Meds by revenue are Aelius Consulting Private Limited, TSM Internet Private Limited, Areca Multitrade Private Limited, Avinash Tradecom Private Limited, Pratham Carbon-Free Vision Private Limited and 3 more, all in the same principal business activity (other professional, scientific and technical activities).
Jaya Bhat Mugulthimoole was appointed as Director on 10 Oct 2022. Rasika Ganapathi Bhat was appointed as Director on 10 Oct 2022.
The registered office of KJ Meds is at A – 104 Dheeraj Valley Bldg 2 Near Sai Baba Complex, Mumbai, Maharashtra, India – 400063.
KJ Meds operates in the chemicals industry, in the other chemical product segment.
The compliance status of KJ Meds is compliant as of 09 August 2026. The company is actively filing with the Registrar of Companies.
KJ Meds can be reached at its registered office: A – 104 Dheeraj Valley Bldg 2 Near Sai Baba Complex, Mumbai, Maharashtra, India – 400063.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
